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Abstract 
Background and aims: Evaluating the impact of coronary revascularization (CR) on 
patients’ Health Related Quality of Life (HRQoL) with a patient-based and disease-specific tool 
is important for drawing conclusions about treatment and outcomes. This study reports on the 
translation, adaptation and psychometric evaluation of a Greek version of the Coronary 
Revascularisation Outcome Questionnaire (CROQ-Gr).  
Methods: A total of 609 (81.7% male) patients who had undergone coronary 
revascularisation (PCI or CABG) were recruited from four hospitals in Athens. After translating 
the CROQ into Greek, a preliminary qualitative study and a pilot quantitative study were 
conducted. A full psychometric evaluation was carried out on the main study’s data.  
Results: The psychometric evaluation demonstrated that the CROQ-Gr is acceptable to 
patients (high response rate, low missing data) and has a good level of reliability [internal 
consistency (>0.70), test-retest reliability (>0.90)] and validity (both content and construct 
validity). 
Conclusions: The results of this study show the CROQ-Gr to be a psychometrically rigorous 
patient-based measure of outcomes of coronary revascularisation. It would be appropriate for use 
in evaluative research as well as a routine clinical tool to aid cardiologists in monitoring the 
outcomes of care. 
Key words: Translation, Validation, HRQoL, PCI, CABG, CROQ 
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Introduction 
Cardiovascular disease is one of the leading causes of mortality globally accounting for 
approximately 17 million deaths annually (1). With respect to medical treatment, invasive and 
surgical coronary procedures have been developed and are widely used for treating coronary 
heart disease (CHD). The two most commonly used types of coronary revascularization (CR) are 
Percutaneous Coronary Interventions (PCI), formerly called Percutaneous Transluminal 
Coronary Angioplasty (PTCA) and generally known as stent placement, and Coronary Artery 
Bypass Grafting (CABG), generally known as bypass surgery. According to research evidence, 
these two procedures have reduced the mortality and morbidity rates of patients with coronary 
diseases (2).  
However, health is not just a biomedical issue. Beyond the survival benefit and relief of 
symptoms, patients’ health-related quality of life (HRQoL) should be considered (3). While 
there is no consensus definition of HRQoL, the most commonly adopted is that of the World 
Health Organization which incorporates physical, psychological and social well-being (4).  
The literature on quality of life demonstrates that monitoring the impact of an intervention on 
patients’ HRQoL allows health professionals to enhance and promote patients’ wellbeing (5), to 
draw valid conclusions about the effectiveness of a specific treatment, to aid clinical decision 
making about the type of treatment that best suits individual needs (6), to clarify issues requiring 
further research such as highlighting additional factors (e.g. duration of hospital stay after 
revascularisation) that may influence outcome in the short and long term and, finally, to develop 
specific (tailored) interventions for enhancing patients’ wellbeing (7). Therefore, a great deal of 
research has been carried out using patient-based instruments in order to determine the level of 
patients’ HRQoL before and after cardiac surgery (8). However, no clear conclusions can be 
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drawn because the literature provides inconsistent results (9). The discrepancy in the literature 
can be partially explained by disagreement regarding the domains of HRQoL that patient-based 
instruments should measure and also by the use of generic instead of disease-specific 
instruments that assess patients’ perception of health status.  
Until recently, there were no validated disease-specific patient-based instruments for 
coronary revascularisation (10). Schroter and Lamping (12) therefore developed the Coronary 
Revascularisation Outcome Questionnaire (CROQ). The use of this disease-specific measure 
might provide further and more accurate knowledge regarding the impact of CR on patients’ 
wellbeing. The CROQ (11) was developed to evaluate HRQoL and health outcomes before and 
after the two common operational coronary procedures, PCI and CABG, capturing aspects of 
recovery not addressed in other heart disease questionnaires. 
The CROQ has four versions, a pre- and (3-month) post-revascularization version for each of 
the PCI and CABG treatments. The two pre-revascularization versions measure four domains 
containing 32 core evaluative items and one descriptive item that it is not taken into account in 
scale scores. Specifically these domains are Symptoms, Physical Functioning, Psychosocial 
Functioning and Cognitive Functioning. The two post-revascularization versions include the 
same four domains plus two additional domains, Satisfaction with Outcome and Adverse Effects  
as well as two items that do not contribute to subscale scores. 
Research demonstrates that the CROQ is valid and reliable in the original English version 
(11) as well as in its Italian (10), Persian (12) and Japanese versions (13). The literature suggests 
that the CROQ is a promising instrument for measuring HRQOL and health outcomes as it is the 
only tool that includes psychosocial and cognitive functioning as well as surgery-specific items 
(14).  In fact, the CROQ has been used to detect the effect of treatment in the short and long term 
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(11) as it is more responsive than other instruments (15) and yields a greater response rate 
compared to other measures (16). Studies using the CROQ  suggest moderate to high effect sizes 
(d ≥ 0.67) of CR on HRQoL domains with the exception of Cognitive Functioning where a small 
effect was found (11).  Moreover, the CROQ has been used in exploring HRQoL across various 
subtypes of coronary revascularization. For example, Angelini et al. (18) found no differences in 
patients’ well-being between those treated with on- or off-pump CABG surgery. Similarly,  
Rogers et al. (19) found no difference in patients’ HRQoL between those treated via left 
anterolateral thoracotomy (ThoraCAB) or via a conventional median sternotomy (17). These 
findings are very important, especially where the Cognitive subdomain is concerned. Previous 
literature suggests that patients undergoing off-pump CABG score higher in the cognitive 
subdomain compared to patients undergoing conventional CABG (18), whereas the CROQ was 
able to detect accurately the lack of cognitive differences after one or other treatment, a finding 
that is supported by recent systematic reviews where authors have focused on studies using 
specialised methods of cognitive testing (19, 20). 
Clearly the CROQ is an essential patient-based measure of disease-specific HRQoL. The aim 
of this study is to develop a psychometrically sound Greek version of the CROQ, the CROQ-Gr.  
 
Method 
Sample and data collection  
After obtaining the approval of the relevant institutional ethics committees (at the University 
of Hertfordshire and of the four participating hospitals), patients were recruited from Tzaneio, 
Thriasio, Attiko and Metropolitan Hospitals, between April 2009 and July 2012. Patients 
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expected to undergo PCI or CABG in allied hospitals during the research period were eligible to 
participate in the study. Exclusion criteria were patients being below 18 years of age and patients 
with an emergency admission.  
 
 
Measures 
The CROQ consists of four versions; one pre-PCI, one post-PCI, one pre-CABG and one 
post-CABG. The two pre-operation versions are identical for the two procedures and capture 
four domains containing 32 core evaluative items (symptoms [7 items], physical functioning [8 
items], psychosocial functioning [14 items] and cognitive functioning [3 items]) and one 
descriptive item that is not taken into account in computing scale scores. The two post-operation 
versions consist of the same four subscales as the pre-operation version as well as three items 
that are not taken account of in computing scale scores and two additional domains at the post-
operation versions are adverse effects (6 items) and satisfaction with outcome (6 items for the 
PCI version and 11 for the CABG version). Total scores are rated on 0-100 scale. Higher scores 
indicate higher HRQoL level. 
In addition to the CROQ-Gr, the Greek version of SF-36v2TM Health Survey (SF-36) (21-23) 
questionnaire was used to test for construct validity. The SF-36v2TM  consists of 36 questions 
focusing on eight areas: physical functioning (PF-10 items), role limitations due to physical 
health problems (RP- 4 items), bodily pain (BP- 2 items), general health perceptions (GH-5 
items), vitality (VT-4 items) tapping energy levels and fatigue, social functioning (SF-2 items), 
role limitations due to emotional problems (RE-3 items) and mental health (MH-5 items). The 
average score of PF, GH, RP, BP are used to create the Physical Components Summary (PCS) 
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while VT, SF, RE, MH are used to create the Mental Components Summary (MCS). Higher 
scores indicate higher HRQoL level. Total scores are rated on 0-100 scale. Higher scores 
indicate higher HRQoL level. 
 
Translation and adaptation 
An instrument that is validated and widely used in one culture, is not necessarily valid and 
reliable in every language and culture and its adaptation requires more than a simple literal 
translation. However, while at least 17 methods of adaptation can be identified (24), the majority 
agree upon a multi-stage procedure. It involves at least two forward translators, one or two back 
translators, a synthesis of findings, a review by an expert panel, pre-testing and a formal 
psychometric testing (24). The approach adopted here is that of the International Quality of Life 
Assessment (IQOLA) (25-32) since this is the approach followed for the cultural adaptation of 
the SF-36 which is the mostly adapted instrument of HRQoL globally. 
After the forward translation, a scientific panel consisting of the principal investigators and a 
bilingual individual revised the preliminary version of the CROQ-Gr. In addition, 25 qualitative 
interviews (10 with patients who had undergone PCI and 15 with patients who had undergone 
CABG) were conducted to ensure content validity, clarity, appropriateness of wording, 
questionnaire format and instructions and feasibility (regarding respondent burden). After minor 
modifications, the final translation back to English was conducted by another bilingual 
individual. Furthermore, a pilot study was conducted with a total of 112 Greek patients who had 
undergone PCI to demonstrate acceptability and reliability (data not shown). 
 
Statistical analysis 
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Analyses are presented as suggested by the original CROQ’s developers (11) and, for 
comparison with the original, their terminology is used. Firstly, descriptive analysis was carried 
out to estimate acceptability and item variance. Reliability analysis was performed using 
Cronbach’s a to estimate internal consistency and intraclass correlation coefficients (ICC) to 
estimate test-retest reliability (test-retest was carried out in a subsample of 20 PCI and 20 CABG 
patients completing measures at baseline and 3 weeks later). Construct validity (within scale) 
was assessed using Principal axis factoring extraction, as per the development of the original 
CROQ, using the 3-month post-CR data. A four-factor solution was expected and, with Varimax 
rotation, was set a priori with coefficient suppression at 0.35. Construct validity (against 
external criteria) was evaluated using Spearman’s rho correlations between the CROQ-Gr and 
SF-36 for 45-52 patients for each of the procedures at baseline and at 3-months post-CR. It was 
expected that Physical Functioning/Symptoms scales of the CROQ-Gr would correlate more 
strongly with the Physical Component Summary of the SF-36 than with the Mental Component 
Summary and that the Psychological Functioning scale of the CROQ-Gr would correlate more 
strongly with the Mental Component Summary of the SF-36 than with the Physical Component 
Summary. No predictions were made as the association between the Cognitive Functioning scale 
of the CROQ and the SF-36. The scoring of the SF-36 was carried out with the use of the Health 
Outcomes Scoring Software 3.0. Data were analysed using SPSS version 20.0 
 
Results 
Following the translation/adaptation and pilot testing of the CROQ-Gr (described in the 
Methods section), 472 Greek patients undergoing coronary revascularization (307 PCI and 165 
CABG) were recruited for the extended psychometric evaluation of all four versions (i.e. the pre- 
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and post- versions for PCI and CABG). Of these, 76.01% (N=359) were men and mean age was 
M=60.4 years, SD=10.8.  
 
Acceptability and reliability (internal consistency and test-retest) 
Most of the CROQ-Gr versions have good acceptability with little missing data. Both 
Cronbach’s a and intraclass correlation coefficients (ICC) exceeded the criterion of 0.70 for all 
scales, demonstrating excellent internal consistency and test-retest reliability (Table 1). 
 
Table 1 about here 
 
Content validity 
Content validity was evaluated during the development of the CROQ-Gr versions and in the 
preliminary translation/adaptation and pilot studies described above (which included a panel of 
experts as well as face-to-face interviews with patients).  
 
Construct validity (within scale) 
In addition to the high levels of internal consistency and intraclass correlation coefficients 
described above, support for the construct validity of the CROQ-Gr can be demonstrated from 
the findings of the factor analysis. For all versions, the Kaiser-Meyer-Olkin test verified 
sampling adequacy (KMO >.78) and Bartlett’s test confirmed sphericity (p<.001). Four factors 
had Eigen values greater than 1 and items loaded on their expected factor (Table 2). The four 
factor model of rotated squared loadings explained between 41.7% and 50.3% of the variance, 
depending on the version. Results were almost identical to the original English version. 
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Table 2 about here 
 
Construct validity (against external criteria) 
Construct validity against external criteria was examined through the correlations between 
the CROQ-Gr and the SF-36 subscales (see Table 3). As expected, the Symptoms and Physical 
Functioning subscales of the CROQ-Gr correlated more strongly with the Physical Component 
Summary of the SF-36 than with the Mental Component Summary. Conversely, the 
Psychological Functioning subscale of the CROQ-Gr correlated more strongly with the Mental 
Component Summary of the SF-36 than with the Physical Component Summary. These results 
were true for both procedures and for both the pre-and post-procedure versions, thus 
demonstrating both convergent and divergent validity. The Cognitive Functioning subscale of 
the CROQ-Gr was not reliably related to any subscales of the SF-36. 
 
Table 3 about here 
 
Discussion 
Following forward and back translation, interviews with patients, pilot testing and, following 
modifications, a full psychometric evaluation of the CROQ, the Greek version of the CROQ 
(CROQ-Gr) was shown to be a practical and psychometrically sound measure of health related 
quality of life and other health issues before and after heart revascularization. It is acceptable to 
patients and can be used in relation to both PCI and CABG. These findings are in accordance 
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with findings reported by the English (11), Italian (10), Persian (12), and Japanese (13) versions 
of the CROQ.  
Due to the current lack of a Greek disease-specific measure of HRQoL and health outcomes 
after CR, it could be argued that the development of the CROQ-Gr is essential. It is a subjective 
measure that enables assessment of both therapeutic procedures from the patient’s point of view 
that, in turn, could allow greater insight concerning patients’ treatment and greater confidence in 
decision making about the type of treatment that best meets patients’ needs. Reviewers (33) 
suggest that, in order to draw clear conclusions about the effectiveness of CR on patients’ 
HRQoL, shape decision making and develop appropriate policy, a combination of both types of 
measures (generic and specific) should be used. The non-significant correlations between some 
of the subscales in the CROQ-Gr and SF-36 suggests that there may indeed be aspects of quality 
of life that are captured in each measure that are not captured by the other; to determine the 
complete picture may, therefore, require the application of both. 
Furthermore, when interpreting the findings, cultural issues (34) should be considered, 
because they could influence the total scores observed for each subscale which, in turn, could 
influence the conclusion about research findings. Specifically, scores obtained by the CROQ-Gr 
in the present study indicate that Greek patients report greater levels of HRQoL compared to 
English patients (11). This may underline the presence of differences in patients’ perceptions of 
wellbeing and thus scores may be culturally influenced. It may be the case that Greek patients 
perceive their HRQoL as “good” despite their health issues. The literature indicates that patients 
in different cultures tend to selectively express symptoms as well as physical and/or 
psychological functioning in culturally acceptable ways (28). Their reporting is based on the 
concept of how people perceive and articulate their physical and mental problems. For instance, 
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individuals in one culture might perceive it to be more acceptable to suppress upsetting thoughts, 
while in other cultures individuals might be more likely to adopt a more active way of 
expressing and facing problems rather than ignoring them. In fact, many researchers examining 
cultural adaptations of measures share the same concern (28). Thus, when researchers and 
clinicians interpret the literature they should bear in mind cultural issues as well.  
Differences in attitudes towards lifestyle factors could also be implicated. Research findings 
reveal that the vast majority of Greeks report low physical activity and tend to avoid exercising, 
walking or running, preferring a sedentary life, driving and using elevators, especially those 
living in urban areas (35). Certainly this is consistent with the reports of some participants in the 
present study for whom items relating to walking 1km or using the stairs were not considered 
relevant and who therefore had difficulty completing this part of the CROQ-Gr. However, this is 
not a static phenomenon and health behaviours such as physical activity are increasing, perhaps 
as a result of public educational interventions for the “therapeutic” role of physical activity that 
took place in Greece after its entry into the EU, particularly amongst younger women (36) and 
people with higher income (37). 
The main limitations of the present study are the non-random sample which diminishes 
claims for generalizability, the likelihood of social desirability bias due to the form of 
administration and the lack of clinical validation.    
Future research could use the CROQ-Gr to address a number of issues. Firstly, repeated 
assessment over time is important to track the trajectory of change within different domains. 
Secondly, identifying aspects of quality of life that are less likely to change following CR is 
important in order to plan additional support. Thirdly, the development of a shorter version 
would be useful for reducing respondent burden and increasing data quality, especially when 
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research aims to explore many related issues (e.g. personality, mood) and thus may use many 
instruments.  
Moreover, health professionals should be encouraged to use the CROQ-Gr for gaining a 
better understanding of the patient’s experience which may facilitate not only doctor-patient 
communication and treatment decisions, but also drawing a clear conclusion about disease 
burden and effectiveness of rehabilitation. 
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